Cargando…

Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese

BACKGROUND: To investigate the influence of hyperhomocysteinemia (HHcy) and metabolic syndrome (MetS) on left ventricular hypertrophy (LVH) in residents in rural Northeast China. METHODS: We performed a cross-sectional baseline data analysis of 6837 subjects (mean age: 54 ± 10 years) recruited from...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Shasha, Chen, Yintao, Yang, Hongmei, Guo, Xiaofan, Zheng, Liqiang, Sun, Yingxian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998833/
https://www.ncbi.nlm.nih.gov/pubmed/32013876
http://dx.doi.org/10.1186/s12872-020-01350-2
_version_ 1783493905963024384
author Yu, Shasha
Chen, Yintao
Yang, Hongmei
Guo, Xiaofan
Zheng, Liqiang
Sun, Yingxian
author_facet Yu, Shasha
Chen, Yintao
Yang, Hongmei
Guo, Xiaofan
Zheng, Liqiang
Sun, Yingxian
author_sort Yu, Shasha
collection PubMed
description BACKGROUND: To investigate the influence of hyperhomocysteinemia (HHcy) and metabolic syndrome (MetS) on left ventricular hypertrophy (LVH) in residents in rural Northeast China. METHODS: We performed a cross-sectional baseline data analysis of 6837 subjects (mean age: 54 ± 10 years) recruited from a rural area of China. Anthropometric indicators were measured according to standard methods. MetS was defined by the modified ATP III criteria. HHcy was defined according to the WHO standard: an Hcy level > 15 μmol/L representing HHcy. Four groups were defined: non-HHcy & non-MetS, HHcy & non-MetS, MetS & non-HHcy and HHcy & MetS. RESULTS: The left ventricular mass index for height(2.7) (LVMH(2.7)) in both sexes was significantly higher in the HHcy & MetS group than in the non-HHcy & non-MetS group (females: 51.23 ± 16.34 vs. 40.09 ± 10.55 g(-2.7), P < 0.001; males: 48.67 ± 12.24 g(-2.7) vs. 42.42 ± 11.38 g(-2.7), P < 0.001). A similar result was observed in those groups when using the left ventricular mass index (LVMI) for body surface area to define LVH (females: 103.58 ± 31.92 g(− 2) vs. 86.63 ± 20.47 g(− 2), P < 0.001; males: 106.10 ± 24.69 g(− 2) vs. 98.16 ± 23.29 g(− 2), P < 0.001). The results of multiple regression analysis indicated that the HHcy & MetS group had a higher risk of LVH than the other three groups (OR: 1.628 for LVMI, P < 0.001, OR: 2.433 for LVMH(2.7), P < 0.001). Moreover, subjects in the HHcy & non-MetS group [OR (95% CI): 1.297 (1.058, 1.591) for LVMI, P < 0.05; OR (95% CI): 1.248 (1.044, 1.492) for LVMH(2.7), P < 0.05] also had a statistically greater risk of LVH than subjects in the non-HHcy & non-MetS group. The HHcy & non-MetS group was also found to be significantly and independently associated with LVH. CONCLUSION: Hyperhomocysteinemia has an independent effect on LVH. The combined effect of MetS and hyperhomocysteinemia might increase the strength of the abovementioned effects.
format Online
Article
Text
id pubmed-6998833
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-69988332020-02-10 Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese Yu, Shasha Chen, Yintao Yang, Hongmei Guo, Xiaofan Zheng, Liqiang Sun, Yingxian BMC Cardiovasc Disord Research Article BACKGROUND: To investigate the influence of hyperhomocysteinemia (HHcy) and metabolic syndrome (MetS) on left ventricular hypertrophy (LVH) in residents in rural Northeast China. METHODS: We performed a cross-sectional baseline data analysis of 6837 subjects (mean age: 54 ± 10 years) recruited from a rural area of China. Anthropometric indicators were measured according to standard methods. MetS was defined by the modified ATP III criteria. HHcy was defined according to the WHO standard: an Hcy level > 15 μmol/L representing HHcy. Four groups were defined: non-HHcy & non-MetS, HHcy & non-MetS, MetS & non-HHcy and HHcy & MetS. RESULTS: The left ventricular mass index for height(2.7) (LVMH(2.7)) in both sexes was significantly higher in the HHcy & MetS group than in the non-HHcy & non-MetS group (females: 51.23 ± 16.34 vs. 40.09 ± 10.55 g(-2.7), P < 0.001; males: 48.67 ± 12.24 g(-2.7) vs. 42.42 ± 11.38 g(-2.7), P < 0.001). A similar result was observed in those groups when using the left ventricular mass index (LVMI) for body surface area to define LVH (females: 103.58 ± 31.92 g(− 2) vs. 86.63 ± 20.47 g(− 2), P < 0.001; males: 106.10 ± 24.69 g(− 2) vs. 98.16 ± 23.29 g(− 2), P < 0.001). The results of multiple regression analysis indicated that the HHcy & MetS group had a higher risk of LVH than the other three groups (OR: 1.628 for LVMI, P < 0.001, OR: 2.433 for LVMH(2.7), P < 0.001). Moreover, subjects in the HHcy & non-MetS group [OR (95% CI): 1.297 (1.058, 1.591) for LVMI, P < 0.05; OR (95% CI): 1.248 (1.044, 1.492) for LVMH(2.7), P < 0.05] also had a statistically greater risk of LVH than subjects in the non-HHcy & non-MetS group. The HHcy & non-MetS group was also found to be significantly and independently associated with LVH. CONCLUSION: Hyperhomocysteinemia has an independent effect on LVH. The combined effect of MetS and hyperhomocysteinemia might increase the strength of the abovementioned effects. BioMed Central 2020-02-03 /pmc/articles/PMC6998833/ /pubmed/32013876 http://dx.doi.org/10.1186/s12872-020-01350-2 Text en © The Author(s) 2020 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Yu, Shasha
Chen, Yintao
Yang, Hongmei
Guo, Xiaofan
Zheng, Liqiang
Sun, Yingxian
Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese
title Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese
title_full Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese
title_fullStr Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese
title_full_unstemmed Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese
title_short Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese
title_sort hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural chinese
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6998833/
https://www.ncbi.nlm.nih.gov/pubmed/32013876
http://dx.doi.org/10.1186/s12872-020-01350-2
work_keys_str_mv AT yushasha hyperhomocysteinemiaaccompanywithmetabolicsyndromeincreasetheriskofleftventricularhypertrophyinruralchinese
AT chenyintao hyperhomocysteinemiaaccompanywithmetabolicsyndromeincreasetheriskofleftventricularhypertrophyinruralchinese
AT yanghongmei hyperhomocysteinemiaaccompanywithmetabolicsyndromeincreasetheriskofleftventricularhypertrophyinruralchinese
AT guoxiaofan hyperhomocysteinemiaaccompanywithmetabolicsyndromeincreasetheriskofleftventricularhypertrophyinruralchinese
AT zhengliqiang hyperhomocysteinemiaaccompanywithmetabolicsyndromeincreasetheriskofleftventricularhypertrophyinruralchinese
AT sunyingxian hyperhomocysteinemiaaccompanywithmetabolicsyndromeincreasetheriskofleftventricularhypertrophyinruralchinese